ANL 18.23 Decreased By ▼ -1.06 (-5.5%)
ASC 13.77 Increased By ▲ 0.32 (2.38%)
ASL 22.25 Increased By ▲ 0.05 (0.23%)
BOP 8.06 Decreased By ▼ -0.12 (-1.47%)
BYCO 7.06 Decreased By ▼ -0.49 (-6.49%)
FCCL 17.41 Decreased By ▼ -0.04 (-0.23%)
FFBL 22.25 Increased By ▲ 0.15 (0.68%)
FFL 15.30 Increased By ▲ 0.10 (0.66%)
FNEL 7.25 Decreased By ▼ -0.15 (-2.03%)
GGGL 16.24 Decreased By ▼ -0.76 (-4.47%)
GGL 37.60 Decreased By ▼ -1.70 (-4.33%)
HUMNL 5.93 Increased By ▲ 0.17 (2.95%)
JSCL 17.90 Decreased By ▼ -0.10 (-0.56%)
KAPCO 35.22 Decreased By ▼ -0.73 (-2.03%)
KEL 3.28 Decreased By ▼ -0.01 (-0.3%)
MDTL 2.32 Decreased By ▼ -0.18 (-7.2%)
MLCF 34.44 Increased By ▲ 0.20 (0.58%)
NETSOL 112.60 Decreased By ▼ -7.25 (-6.05%)
PACE 4.62 Decreased By ▼ -0.32 (-6.48%)
PAEL 27.80 Increased By ▲ 1.27 (4.79%)
PIBTL 8.70 Decreased By ▼ -0.01 (-0.11%)
POWER 7.15 Decreased By ▼ -0.10 (-1.38%)
PRL 16.10 Decreased By ▼ -0.87 (-5.13%)
PTC 9.45 Decreased By ▼ -0.20 (-2.07%)
SILK 1.48 Decreased By ▼ -0.02 (-1.33%)
SNGP 45.55 Increased By ▲ 0.45 (1%)
TELE 16.17 Decreased By ▼ -1.31 (-7.49%)
TRG 159.48 Decreased By ▼ -1.52 (-0.94%)
UNITY 31.20 Decreased By ▼ -0.60 (-1.89%)
WTL 2.76 Decreased By ▼ -0.09 (-3.16%)
BR100 4,676 Decreased By ▼ -41.96 (-0.89%)
BR30 22,049 Decreased By ▼ -270.91 (-1.21%)
KSE100 44,818 Decreased By ▼ -255.76 (-0.57%)
KSE30 17,642 Decreased By ▼ -100.19 (-0.56%)

Coronavirus
HIGH Source: covid.gov.pk
Pakistan Deaths
27,597
3124hr
Pakistan Cases
1,240,425
1,75724hr
3.61% positivity
Sindh
455,808
Punjab
429,081
Balochistan
32,861
Islamabad
105,120
KPK
173,210
World

South Korea's SK bioscience to invest $132 million to boost vaccine production

  • SK bioscience said it plans to add some 99,130 square metres of additional production space in the area.
21 Jun 2021

SEOUL: South Korea's SK bioscience said on Monday it plans to expand vaccine production by investing about 150 billion won ($132 million) by 2024 to add production capacity, as well as equipping its plant to make newer mRNA and viral vector vaccines.

The vaccine maker said in a statement it has signed an agreement with the government of North Gyeongsang Province and the city of Andong, about 190 km (118 miles) southeast of Seoul, to expand its plant there and buy new land.

SK bioscience said it plans to add some 99,130 square metres of additional production space in the area.

Its Andong plant produces COVID-19 vaccines developed by AstraZeneca Plc and Novavax Inc.

The company said last week the facility had received European Union Good Manufacturing Practices (GMP) certification, enabling SK to export vaccines to Europe.

Comments

Comments are closed.